SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML 0000899243-19-014838.pdf 0000899243-19-014838.rtf	May 28, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001564590-19-016554.pdf 0001564590-19-016554.rtf 0001564590-19-016554.xls	May 07, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0001564590-19-016564.pdf 0001564590-19-016564.rtf 0001564590-19-016564.xls EX-101.INS - XBRL INSTANCE DOCUMENT	May 07, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0000899243-19-012357.pdf 0000899243-19-012357.rtf	May 06, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-012105.pdf 0000899243-19-012105.rtf	May 03, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-125291.pdf 0001193125-19-125291.rtf 0001193125-19-125291.xls	Apr 29, 2019	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Proxy Filings	Eidos Therapeutics, Inc.
View HTML 0000899243-19-011239.pdf 0000899243-19-011239.rtf	Apr 26, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-010707.pdf 0000899243-19-010707.rtf	Apr 16, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001564590-19-011571.pdf 0001564590-19-011571.rtf 0001564590-19-011571.xls	Apr 15, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML nc10001281x1_EIDOS_Annual Report 2018_E-bookproof_v2.pdf 3 MB 0001564590-19-011575.rtf 0001564590-19-011575.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Apr 15, 2019	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	Eidos Therapeutics, Inc.